C Rozmán

16.1k total citations · 3 hit papers
309 papers, 11.5k citations indexed

About

C Rozmán is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, C Rozmán has authored 309 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Hematology, 135 papers in Genetics and 69 papers in Pathology and Forensic Medicine. Recurrent topics in C Rozmán's work include Chronic Lymphocytic Leukemia Research (94 papers), Lymphoma Diagnosis and Treatment (62 papers) and Hematopoietic Stem Cell Transplantation (47 papers). C Rozmán is often cited by papers focused on Chronic Lymphocytic Leukemia Research (94 papers), Lymphoma Diagnosis and Treatment (62 papers) and Hematopoietic Stem Cell Transplantation (47 papers). C Rozmán collaborates with scholars based in Spain, United States and France. C Rozmán's co-authors include Emilio Montserrat, Gale Rp, AA Rimm, Emili Montserrat, Francisco Cervantes, MM Horowitz, Olle Ringdén, B Speck, Sondel Pm and JH Kersey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

C Rozmán

297 papers receiving 11.0k citations

Hit Papers

Graft-versus-leukemia reactions after bone marrow transpl... 1987 2026 2000 2013 1990 1987 1995 500 1000 1.5k 2.0k

Peers

C Rozmán
Comparison fields: 5 of 131
  • Hematology 5.8k
  • Genetics 4.5k
  • Immunology 3.3k
  • Pathology and Forensic Medicine 2.9k
  • Oncology 2.3k
Replace Alberto Bosi with:
Alberto Bosi Italy
Bruno Varet France
Howard M. Shulman United States
Augustin Ferrant Belgium
Enrica Morra Italy
Jürgen Finke Germany
Karl G. Blume United States
Koen van Besien United States
Enric Carreras Spain
Hanneke C. Kluin‐Nelemans Netherlands
Alberto Bosi Italy View profile →
Citations per field, relative to C Rozmán
C Rozmán · 1×
Citations per year, relative to C Rozmán
C Rozmán · 1×

Countries citing papers authored by C Rozmán

Since Specialization
Citations

This map shows the geographic impact of C Rozmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Rozmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Rozmán more than expected).

Fields of papers citing papers by C Rozmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Rozmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Rozmán. The network helps show where C Rozmán may publish in the future.

Co-authorship network of co-authors of C Rozmán

This figure shows the co-authorship network connecting the top 25 collaborators of C Rozmán. A scholar is included among the top collaborators of C Rozmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Rozmán. C Rozmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 69
2 7
3 84
4 143
5 57
6 2
7
[Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
1
8
Aspectes de l'educació mèdica per a l'adquisició de la competència clínica
1
9 3
10 11
11 6
12
[Idiopathic myelofibrosis: clinical course, survival, and causes of death in a series of 60 patients].
2
13 13
14 13
15
[Prolymphocyte T-cell leukemia: quantitative cytomorphological, cytochemical and ultrastructural study (author's transl)].
1
16
[Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)].
2
17
[The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)].
2
18
[Interest of the staging of chronic lymphocytic leukaemia (author's transl)].
3
19
[Ultrastructural aspects of dyserythropoiesis in the refractory anaemias (author's transl)].
2
20
[NASAL CARRIERS OF STAPHYLOCOCCUS AMONG THE STAFF OF VARIOUS MEDICAL INSTITUTIONS IN BARCELONA].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026